National and Kapodistrian University of Athens
Χαρτογράφηση της νοσηρότητας της οζώδους σκλήρυνσης στην Ελλάδα: κλινικά, απεικονιστικά και γενετικά δεδομένα
Abstract
dc:descriptionIntroduction: Tuberous Sclerosis (TS) is a rare neurocutaneous disorder with diverse manifestations that typically present early in childhood. Objective: To describe the characteristics of patients with TS in Greece, including clinical presentation, neuroimaging findings, and genetic information, with a particular focus on rare manifestations. Methodology: A group of 115 patients was gathered from pediatric neurologists and other specialists (nephrologists, geneticists) across Greece. Patients and/or their guardians provided information on medical history, clinical characteristics, and current status. Rare manifestations were analysed with respect to age of onset and management, and genotype-phenotype correlation for the TSC1 and TSC2 genes was studied. Results: The analysis included 115 TS patients, 60 males and 55 females. Median age at symptom onset was 0.8 years (range 0-15), and at diagnosis 1.2 years (range 0-43). The main presenting symptom was seizures (70.4%), with 104 patients (90.4%) eventually developing epilepsy, with a median age of onset at 0.9 years (range 0.04-15). Genetic testing was conducted on 66 patients, revealing 16 with TSC1 gene variants (13.9%), 46 with TSC2 variants (40%), and four negative results (3.5%). The TSC1:TSC2 ratio was 1:2.87. Brain lesions were observed in 112 patients, including cortical tubers (CT) (93.9%), subependymal nodules (SEN) (92.2%), subependymal giant cell astrocytoma (SEGA) (20%), migratory lines (15.7%), cerebellar atrophy (2.6%), and Chiari I malformation (1.7%). Intellectual disability was noted in 57 patients (49.6%), with mild in 9 (7.8%), moderate in 18 (15.7%), severe in 9 (7.8%), and profound in 21 (18.3%). Autism spectrum disorder (ASD) was identified in 22.6% of patients, attention deficit hyperactivity disorder (ADHD) in 9.6%, and behavioral issues (BI) were reported in 20.9%. Renal manifestations were present in 68 patients (59.1%). Cutaneous involvement was observed in all patients, including hypomelanotic macules (97.4%), angiofibromas (39.1%), confetti lesions (14.8%), shagreen patches (27.8%), ungual fibromas (13%), and poliosis (1.7%). Dental manifestations were observed in 7 patients. Cardiac involvement with rhabdomyomas and arrhythmias was noted in 39 patients (34%) out of 114 examined. Eye manifestations were observed in 20 patients (17.4%). Pulmonary testing was performed in 11 of 46 adult patients (24% of the adult cohort). Finally, we report several rare manifestations, including high-grade glioma in a pediatric patient, diffuse lipomatosis, pancreatic neuroendocrine tumors, rectal polyps, and erythema nodosum presented in a patient on everolimus therapy, further highlighting the systemic complexity and malignancy risks in TS. Conclusions: The characteristics and manifestations of TS patients in Greece align with the existing literature, with interesting observations of rare manifestations, such as high-grade glioma and diffuse lipomatosis, at a young age. Rare manifestations and associated malignancies require ongoing lifelong monitoring of potentially affected organs to reduce the risk of complications and enable timely medical intervention.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Spanou, Maria
- Σπανού, Μαρία
Subjects
dc:subject × 18- Οζώδης σκλήρυνση
- Σπάνιες εκδηλώσεις
- Διεθνής μελέτη
- Γλοίωμα υψηλού βαθμού κακοήθειας
- Νευροενδοκρινής όγκος παγκρέατος
- Tuberous sclerosis complex
- Rare manifestations
- National cohort study
- High grade gliomas
- Pancreatic neuroendocrine neoplasms
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική νευρολογία
- Κλινική ιατρική, γενικά
- Clinical Medicine
- Medical and Health Sciences
- Clinical Neurology
- Clinical medicine, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60625